Skip to content
Trial Eligibility
Menu

Localizing Epileptic Networks Using MRI and iEEG

NCT04649008

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Upon successful completion of this study, the investigators expect the study's contribution to be the development of noninvasive imaging biomarkers to predict IEEG functional dynamics and epilepsy surgical outcomes. Findings from the present study may inform current and new therapies to map and alter seizure spread, and pave the way for less invasive, better- targeted, patient-specific interventions with improved surgical outcomes.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Epilepsy
  • Epilepsy Intractable
  • Epilepsy, Temporal Lobe

Eligibility basics and study details

Study type
Interventional
Phase
Early Phase 1
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Pennsylvania
Last updated on ClinicalTrials.gov
February 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.